Viking Therapeutics Inc. (VKTX)
NASDAQ · Healthcare
Viking Therapeutics Inc. Net Income 2014–2025
Viking Therapeutics Inc. annual/quarterly net income history and growth rate from 2014 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Viking Therapeutics Inc. net income for the quarter ending March 31, 2026 was -158.3 M, a 246.98% increase year-over-year.
- Viking Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -360.3 M, a 271.14% increase year-over-year.
- Viking Therapeutics Inc. annual net income for 2025 was -359.6 M, a 227.05% increase from 2024.
- Viking Therapeutics Inc. annual net income for 2024 was -110.0 M, a 28.02% increase from 2023.
- Viking Therapeutics Inc. annual net income for 2023 was -85.9 M, a 24.73% increase from 2022.
- Viking Therapeutics Inc. annual net income for 2022 was -68.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Viking Therapeutics Inc. Net Income — FAQ
Viking Therapeutics Inc. (VKTX) net income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Viking Therapeutics Inc.'s net income?
Viking Therapeutics Inc. (VKTX) reported net income of -$360M for fiscal 2025.
Where can I see VKTX's net income history?
The chart and table above show Viking Therapeutics Inc.'s net income by year and by quarter, including the growth rate.